Upon reading this thread, I did little research to find below schedule.
http://www.painmed.org/PracticeMana...eleases-2014-medicare-physician-fee-schedule/
The article suggests that while overall reimbursement did go down, they did increase reimbursement for in-office procedure (63650). But then there was also a doctor (presumably) who commented that even with that increase, L8680 change(?) is making overall reimbursement reduction by 50%? But isn't L8680 spinal implant related code?
I'm trying to catch up on these changes and got little confused. Would anyone here be willing to explain how these changes actually effect the in-practice procedures?
Thank you for your help!
This has all been gone over as nauseum on the 2014 billing update and RIP Stim threads, but to summarize (of the top of my head):
Last year 2 lead (16 contact, >$400 per contact) in office stim trial paid approx $5700 for the leads (L8680 = $6700 minus approx $1000 for 2 leads). L 8680 now no longer pays $6700. It now pays zero dollars.
63650 payed approx $437 per lead last year. It now pays approx $1349 for 1 lead and $647 for the second. Subtract from this lead cost, which this year has dropped from about $1,000 for 2 leads last year, to $200-$400 for two leads this year.
So last year a 2 lead in office stim trial netted >$6,000 (Medicare, L8680+63650-lead cost)
This year a 2 lead stim trial in office nets $1596-$1796 ($1996 for 63650s-lead cost)
That's a 70-80% cut depending on your lead price, how many leads/contacts you do, etc.
Of course it all varies based on the secondary insurance, your state etc. of course, none of this applies to private insurances, ASC or Hosp procedures.
This is for Medicare. Check here:
http://asipp.org/documents/Physicians2014F.pdf